Previous studies have demonstrated that tumor-derived CCL15 promotes the progression of hepatocellular carcinoma by modulating immune cell recruitment and activation, thereby maintaining an immunosuppressive microenvironment 4. The gene discussed is CCL15; the disease is neoplasm.